SLPI and bacterial infectious disease: FP also suppressed RV induction of secretory leukoprotease inhibitor (SLPI) protein (~50% reduction, Fig. 2f), an antimicrobial peptide (AMP) implicated in protection against secondary bacterial infection following RV infection in COPD14.